Modification of polyethylene glycol onto solid lipid nanoparticles encapsulating a novel chemotherapeutic agent (PK-L4) to enhance solubility for injection delivery - Concepedia

Concepedia

Publication | Open Access

Modification of polyethylene glycol onto solid lipid nanoparticles encapsulating a novel chemotherapeutic agent (PK-L4) to enhance solubility for injection delivery

DOI Full Paper Access

20

Citations

38

References

2012

Year

Yi‐Ping Fang, Yaw‐Bin Huang, Chernh-Chyi Tzeng, Chen, Hong, Tsai, Tsai, Pao-Chu Wu

International Journal of Nanomedicine

Abstract

Sufficient amounts of PK-L4 were entrapped in the SLNs, and the pharmacokinetic behavior of PK-L4-loaded SLNs was established. This formulation successfully resolved the delivery problem, and the drug was localized in particular organs.

References

	Year	Citations
Surface modification of nanoparticles to oppose uptake by the mononuclear phagocyte system Gert Storm, Sheila O. Belliot, Toos Daemen, Advanced Drug Delivery Reviews NanoparticlesEngineeringNanomaterialsNanotechnologyNano-drug Delivery	1995	862
Effect of light and temperature on zeta potential and physical stability in solid lipid nanoparticle (SLN™) dispersions C. Freitas, Rainer Müller International Journal of Pharmaceutics NanoparticlesLipid PreparationColloid ChemistryPhysical StabilityEngineering	1998	674
Characterization of Low- and Very-Low-Density Hepatitis C Virus RNA-Containing Particles Patrice André, Florence Komurian-Pradel, Séverine Deforges, Journal of Virology	2002	656
Preparation, characterization and in vitro release kinetics of clozapine solid lipid nanoparticles Vobalaboina Venkateswarlu, K Manjunath Journal of Controlled Release NanoparticlesLipid PreparationEngineeringNanomaterialsNanotechnology	2004	552
Importance of solid lipid nanoparticles (SLN) in various administration routes and future perspectives. Melike Üner, Gülgün Yener PubMed NanoparticlesNanomedicineDrug IncorporationLipid PreparationFuture Perspectives	2007	541
Correlation between long-term stability of solid lipid nanoparticles (SLN™) and crystallinity of the lipid phase C. Freitas, Rainer Müller European Journal of Pharmaceutics and Biopharmaceutics NanoparticlesLipid PreparationEngineeringNanomaterialsNanotechnology	1999	471
The production and characteristics of solid lipid nanoparticles (SLNs) Dongzhi Hou, Changsheng Xie, Kaijin Huang, Biomaterials NanoparticlesEngineeringNanomaterialsSolid Lipid NanoparticlesChemistry	2003	432
Pharmacokinetics, tissue distribution and bioavailability of clozapine solid lipid nanoparticles after intravenous and intraduodenal administration K Manjunath, Vobalaboina Venkateswarlu Journal of Controlled Release NanomedicinePharmaceutical ScienceIntraduodenal AdministrationPharmacologyTissue Distribution	2005	374
Effect of PEG conformation and particle size on the cellular uptake efficiency of nanoparticles with the HepG2 cells Yong Hu, Jingwei Xie, Yen Wah Tong, Journal of Controlled Release NanoparticlesNanomedicineEngineeringProtein NanoparticlesNanomaterials	2006	345
Magnetic brain tumor targeting and biodistribution of long-circulating PEG-modified, cross-linked starch-coated iron oxide nanoparticles Adam J. Cole, Allan E. David, Jianxin Wang, Biomaterials NanoparticlesNanomedicineMagnetismNeuro-oncologyLong-circulating Peg-modified	2011	235

Page 1